Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.53 - $0.93 $3,289 - $5,771
6,206 Added 29.07%
27,553 $15,000
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $312 - $565
-496 Reduced 2.27%
21,347 $17,000
Q3 2023

Nov 13, 2023

SELL
$1.12 - $1.88 $89,824 - $150,776
-80,200 Reduced 78.59%
21,843 $24,000
Q2 2023

Jul 31, 2023

SELL
$1.31 - $2.04 $349 - $544
-267 Reduced 0.26%
102,043 $163,000
Q1 2023

May 10, 2023

BUY
$1.45 - $2.95 $21,866 - $44,486
15,080 Added 17.29%
102,310 $155,000
Q4 2022

Feb 07, 2023

SELL
$2.02 - $3.25 $4,040 - $6,500
-2,000 Reduced 2.24%
87,230 $209,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $111,563 - $178,728
56,920 Added 176.17%
89,230 $183,000
Q2 2022

Aug 12, 2022

SELL
$1.3 - $2.64 $2,275 - $4,620
-1,750 Reduced 5.14%
32,310 $63,000
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $6,107 - $9,018
2,599 Added 8.26%
34,060 $84,000
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $3,600 - $7,077
-1,233 Reduced 3.77%
31,461 $101,000
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $9,521 - $12,676
1,912 Added 6.21%
32,694 $172,000
Q2 2021

Aug 13, 2021

BUY
$2.56 - $5.49 $1,228 - $2,635
480 Added 1.58%
30,782 $169,000
Q1 2021

May 14, 2021

SELL
$2.69 - $5.25 $839 - $1,638
-312 Reduced 1.02%
30,302 $82,000
Q4 2020

Feb 12, 2021

SELL
$3.17 - $4.49 $15 - $22
-5 Reduced 0.02%
30,614 $97,000
Q3 2020

Nov 09, 2020

BUY
$2.98 - $5.2 $3,760 - $6,562
1,262 Added 4.3%
30,619 $122,000
Q4 2018

Feb 07, 2019

BUY
$1.59 - $2.66 $3,816 - $6,384
2,400 Added 8.9%
29,357 $70,000
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $1,113 - $1,694
700 Added 2.67%
26,957 $58,000
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $187 - $385
83 Added 0.32%
26,257 $60,000
Q1 2018

May 15, 2018

BUY
$3.51 - $6.04 $12,636 - $21,744
3,600 Added 15.95%
26,174 $123,000
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.78 $73,591 - $107,903
22,574
22,574 $74,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.